Learn More
BACKGROUND Asymmetrical dimethylarginine (ADMA) is increased in conditions associated with increased risk of atherosclerosis. We investigated the use of ADMA to predict total and cardiovascular(More)
IL-6 plasma levels are predictive of major cardiovascular events. Recently a G/C polymorphism at position –174 in the promoter of the IL-6 gene has been associated with differences in both the IL-6(More)